Register Login
Register to leave comments
  • News bot Oct. 30, 2025, 8:38 p.m.

    🔍 MAHON PAUL A (Executive)

    Company: UNITED THERAPEUTICS Corp (UTHR)

    Report Date: 2025-10-30

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 11,000
    • Total shares sold: 22,000

    Detailed Transactions and Holdings:

    • Acquired 11,000 shares of Common Stock at $135.42 per share (Direct)
      Date: 2025-10-30 | Code: M | equity_swap_involved: false | shares_owned_after: 47,781.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 642 shares of Common Stock at $447.3438 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 47,139.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,143 shares of Common Stock at $448.5615 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 45,996.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 3,441 shares of Common Stock at $449.464 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 42,555.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 2,247 shares of Common Stock at $450.636 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 40,308.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 1,849 shares of Common Stock at $451.5696 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 38,459.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 1,285 shares of Common Stock at $452.3293 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 37,174.00 | transaction_form_type: 4 | Footnotes: F1, F7
    • Sold 393 shares of Common Stock at $454.1471 per share (Direct)
      Date: 2025-10-30 | Code: S | equity_swap_involved: false | shares_owned_after: 36,781.00 | transaction_form_type: 4 | Footnotes: F1, F8
    • Sold 11,000 shares of Stock Option at $135.42 per share (Derivative)
      Date: 2025-10-30 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 22,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.
    • F2: This transaction was executed in multiple trades at prices ranging from $446.855 to $447.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F3: This transaction was executed in multiple trades at prices ranging from $447.94 to $448.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F4: This transaction was executed in multiple trades at prices ranging from $448.95 to $449.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F5: This transaction was executed in multiple trades at prices ranging from $450.03 to $451.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F6: This transaction was executed in multiple trades at prices ranging from $451.04 to $452.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F7: This transaction was executed in multiple trades at prices ranging from $452.10 to $452.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F8: This transaction was executed in multiple trades at prices ranging from $453.90 to $454.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Search

News categories